Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Application | Utility: NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING Filling date: 7 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: ANTI-TREM-1 ANTIBODIES AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: PYRROLIDINONE DERIVATIVES AS FORMYL PEPTIDE 2 RECEPTOR AGONISTS Filling date: 7 Sep 2025 Issue date: 6 Jan 2022 |
Grant | Utility: Additive systems for use in protein PEGylation Filling date: 7 Sep 2025 Issue date: 4 Jan 2022 |
Grant | Utility: Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) Filling date: 7 Sep 2025 Issue date: 4 Jan 2022 |
Application | Utility: ANTI-TREM-1 ANTIBODIES AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: METHOD OF TREATING LUNG CANCER Filling date: 7 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: METHODS FOR THE SELECTION OF BINDING PROTEINS Filling date: 7 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: ANTI-IDO ANTIBODY AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS Filling date: 7 Sep 2025 Issue date: 30 Dec 2021 |
Grant | Utility: Anti-ICOS agonist antibodies and uses thereof Filling date: 7 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Cytokine profiling analysis Filling date: 7 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: SYNTHETIC PROCESSES FOR THE PRODUCTION OF 1-((3S,4R)-4-(2,6-DIFLUORO-4-METHOXYPHENYL)-2-OXOPYRROLIDIN-3-YL)-3-PHENY- LUREA Filling date: 7 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: SUBSTITUTED INDOLE DIMER COMPOUNDS Filling date: 7 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: ANTI-MERTK ANTIBODIES FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 23 Dec 2021 |
Grant | Utility: Serum albumin-binding fibronectin type III domains Filling date: 7 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 7 Sep 2025 Issue date: 21 Dec 2021 |
Application | Utility: PET-IMAGING IMMUNOMODULATORS Filling date: 7 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: HANDHELD MEDICAMENT DISPENSER Filling date: 7 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: METHODS OF TREATING TUMOR Filling date: 7 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: RADIOLIGANDS FOR IMAGING THE LPA1 RECEPTOR Filling date: 7 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: MULTICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Filling date: 7 Sep 2025 Issue date: 9 Dec 2021 |
Grant | Utility: Diazaspiro ROCK inhibitors Filling date: 7 Sep 2025 Issue date: 7 Dec 2021 |
Application | Utility: PHENYLPYRROLIDINONE FORMYL PEPTIDE 2 RECEPTOR AGONISTS Filling date: 7 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-- YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE Filling date: 7 Sep 2025 Issue date: 2 Dec 2021 |
Grant | Utility: Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides Filling date: 7 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists Filling date: 7 Sep 2025 Issue date: 30 Nov 2021 |
Application | Utility: COMBINATION THERAPY USING AN ANTI-FUCOSYL-GM1 ANTIBODY AND AN ANTI-CD137 ANTIBODY Filling date: 7 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3 Filling date: 7 Sep 2025 Issue date: 25 Nov 2021 |
Grant | Utility: Isoxazole o-linked carbamoyl cyclohexyl acids as LPA antagonists Filling date: 7 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Antibody polypeptides that antagonize CD40L Filling date: 7 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists Filling date: 7 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitors Filling date: 7 Sep 2025 Issue date: 23 Nov 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 7 Sep 2025 Issue date: 18 Nov 2021 |
Grant | Utility: PD-L1 binding polypeptides for imaging Filling date: 7 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Isofuranone compounds useful as HPK1 inhibitors Filling date: 7 Sep 2025 Issue date: 9 Nov 2021 |
Application | Utility: Miniaturized Dystrophins Having Spectrin Fusion Domains and Uses Thereof Filling date: 7 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: Combination Therapy for Melanoma Filling date: 7 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A PD-1 PATHWAY INHIBITOR, AND AN IMMUNOTHERAPEUTIC AGENT Filling date: 7 Sep 2025 Issue date: 4 Nov 2021 |
Grant | Utility: Fibronectin based scaffold proteins having improved stability Filling date: 7 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Benzofuran derivatives for the treatment of hepatitis C Filling date: 7 Sep 2025 Issue date: 2 Nov 2021 |
Application | Utility: GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 28 Oct 2021 |
Grant | Utility: Anti-TREM-1 antibodies and uses thereof Filling date: 7 Sep 2025 Issue date: 26 Oct 2021 |
Application | Utility: ANTIBODIES TO TIGIT Filling date: 7 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT Filling date: 7 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: TETRAHYDROPYRAN-BASED THIODISACCHARIDE MIMICS AS GALECTIN-3 INHIBITORS Filling date: 7 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: IMIDAZOPYRIDAZINE COMPOUNDS Filling date: 7 Sep 2025 Issue date: 21 Oct 2021 |
Grant | Utility: Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR Filling date: 7 Sep 2025 Issue date: 19 Oct 2021 |
Application | Utility: OXABICYCLO ACIDS AS LPA ANTAGONISTS Filling date: 7 Sep 2025 Issue date: 14 Oct 2021 |
Showing 150 to 200 of 772 patents.